AU558669B2 - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
AU558669B2
AU558669B2 AU49863/85A AU4986385A AU558669B2 AU 558669 B2 AU558669 B2 AU 558669B2 AU 49863/85 A AU49863/85 A AU 49863/85A AU 4986385 A AU4986385 A AU 4986385A AU 558669 B2 AU558669 B2 AU 558669B2
Authority
AU
Australia
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU49863/85A
Other versions
AU4986385A (en
Inventor
Tatsuo Hirakawa
Hiroyuki Imaizumi
Takihiro Inaba
Yoshinori Konishi
Hirokazu Narita
Hiroshi Sadaki
Isamu Saikawa
Masaru Tai
Hideo Taki
Yasuo Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of AU4986385A publication Critical patent/AU4986385A/en
Application granted granted Critical
Publication of AU558669B2 publication Critical patent/AU558669B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49863/85A 1980-09-25 1985-11-13 Cephalosporin derivatives Expired AU558669B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP55132253A JPS5758689A (en) 1980-09-25 1980-09-25 Novel preparation of 7-substituted or unsubstituted amino-3-substituted methylcephem carboxylic acids
JP55-132253 1980-09-25
JP55-158184 1980-11-12
JP55-175263 1980-12-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU75438/81A Division AU550330B2 (en) 1980-09-25 1981-09-17 Cephalosporin derivatives with a broad antibacterial spectrum 276

Publications (2)

Publication Number Publication Date
AU4986385A AU4986385A (en) 1986-03-20
AU558669B2 true AU558669B2 (en) 1987-02-05

Family

ID=15076944

Family Applications (2)

Application Number Title Priority Date Filing Date
AU49863/85A Expired AU558669B2 (en) 1980-09-25 1985-11-13 Cephalosporin derivatives
AU49860/85A Expired AU558586B2 (en) 1980-09-25 1985-11-13 Cephalosporin derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU49860/85A Expired AU558586B2 (en) 1980-09-25 1985-11-13 Cephalosporin derivatives

Country Status (10)

Country Link
JP (1) JPS5758689A (en)
AU (2) AU558669B2 (en)
BE (1) BE890499A (en)
CS (1) CS236493B2 (en)
GB (2) GB8333402D0 (en)
HU (1) HU188021B (en)
MX (1) MX9046A (en)
PL (1) PL137674B1 (en)
SU (3) SU1318144A3 (en)
ZA (1) ZA816576B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
JPH0390112U (en) * 1989-12-29 1991-09-13

Also Published As

Publication number Publication date
CS236493B2 (en) 1985-05-15
SU1318144A3 (en) 1987-06-15
PL238228A1 (en) 1983-05-23
ZA816576B (en) 1982-09-29
SU1308198A3 (en) 1987-04-30
PL137674B1 (en) 1986-07-31
AU4986085A (en) 1986-03-20
MX9046A (en) 1994-02-28
AU558586B2 (en) 1987-02-05
JPS6210512B2 (en) 1987-03-06
AU4986385A (en) 1986-03-20
GB8333401D0 (en) 1984-01-25
HU188021B (en) 1986-03-28
GB8333402D0 (en) 1984-01-25
SU1350166A1 (en) 1987-11-07
BE890499A (en) 1982-03-25
JPS5758689A (en) 1982-04-08

Similar Documents

Publication Publication Date Title
AU547984B2 (en) Cephalosporin derivatives
AU542623B2 (en) 1-hydroxyethyl-azole derivatives
AU544723B2 (en) Imidazolylpropanol derivatives
GB2136420B (en) Cephalosporin derivatives
AU7517181A (en) Cephalosporin derivatives
AU540898B2 (en) 17-disubstituted-androst-4-en-3-one derivatives
AU2174783A (en) 3-thiovinyl cephalosporin derivatives
AU534878B2 (en) Amino-saccharide derivatives
AU562776B2 (en) Cephalosporin derivatives
AU544527B2 (en) Bis-carboxamide derivatives
AU545357B2 (en) Triazolo-benzodiazepine derivatives
AU551238B2 (en) 1-hydroxy-2 -fluorocholecalciferol derivatives
DE3173789D1 (en) Cephalosporin derivatives
AU544907B2 (en) Isonicotinanilide derivatives
AU538505B2 (en) Phenoxy-aminopropanol derivatives
AU540239B2 (en) 2-guanidinothiazole derivatives
AU539443B2 (en) Phenoxybutyltriazole derivatives
AU539837B2 (en) Penicillin derivatives
AU526941B2 (en) Pyrazole-substituted oximino-cyano-acetamide derivatives
AU558586B2 (en) Cephalosporin derivatives
AU7133381A (en) Cephalosporin derivatives
AU7134881A (en) Penicillin derivatives
AU546730B2 (en) Cephalosporin derivatives
AU536771B2 (en) Cephalosporin derivatives
AU541157B2 (en) Pyridinethiolato-aluminium derivatives

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired